Attending this World Congress on Biologics and Biosimilars during May 18-19, 2026 at Barcelona, Spain, presents a valuable opportunity for professionals, researchers, academics, and industry leaders involved in the development, regulation, and commercialization of biosimilar and biologic medicines. Biosimilars Conference serves as a dynamic platform for knowledge exchange, professional networking, and staying updated with the rapidly evolving landscape of biosimilar therapies. As global demand for cost-effective biologic alternatives continues to rise, understanding the complexities and advancements in biosimilars is essential for anyone involved in pharmaceutical sciences, regulatory affairs, clinical research, or healthcare policy. The event typically brings together a diverse community of stakeholders, including scientists, regulatory authorities, healthcare providers, biotech companies, and academic institutions, fostering an environment where ideas are exchanged, collaborations are formed, and innovations are showcased.